Back
#1
23.3%
Top 36%
18.6%
Top 12%
8.2%
Top 54%
5.3%
Top 4%
4.4%
Top 3%
3.3%
Top 6%
2.0%
Top 53%
1.6%
Top 17%
1.6%
Top 11%
1.6%
Top 8%
1.6%
Top 19%
1.6%
Top 25%
1.4%
Top 22%
1.4%
Top 9%
1.2%
Top 8%
1.2%
Top 19%
1.2%
Top 22%
0.7%
Top 10%
0.7%
Top 20%
0.7%
Top 4%
0.7%
Understanding the key determinants of an HPV therapeutic vaccine: a modeling analysis
2023-12-04
public and global health
Title + abstract only
View on medRxiv
Show abstract
Despite incredibly effective tools to prevent HPV infection and treat precancerous lesions, the scale-up of existing interventions in most low and middle-income countries has been slow, leaving a residual burden of invasive cervical cancer that will persist for decades. An HPV therapeutic vaccine may overcome some of the scalability and infrastructure challenges of traditional screening and treatment programs, though its potential public health value depends upon its characteristics, delivery st...
Predicted journal destinations
1
eLife
262 training papers
2
PLOS ONE
1737 training papers
3
Nature Communications
483 training papers
4
Scientific Reports
701 training papers
5
BMC Medicine
155 training papers
6
Vaccine
140 training papers
7
PLOS Computational Biology
141 training papers
8
BMJ Open
553 training papers
9
Clinical Infectious Diseases
219 training papers
10
BMJ Global Health
95 training papers
11
Proceedings of the National Academy of Sciences
100 training papers
12
BMC Public Health
148 training papers
13
PLOS Global Public Health
287 training papers
14
Frontiers in Public Health
135 training papers
15
Nature Medicine
88 training papers
16
Vaccines
131 training papers
17
JAMA Network Open
125 training papers
18
PLOS Medicine
95 training papers
19
Epidemics
96 training papers
20
npj Digital Medicine
85 training papers
21
Cancer Medicine
17 training papers